SCHEMBL29618360

SCHEMBL29618360

CS(=O)(=O)N1CCN(c2ccc(Nc3nccc(-c4cccnc4)n3)cn2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVR1 Q04771 4/20 0.54
ABL1 P00519 6/20 0.52
PRKCA P17252 5/20 0.52
PRKCD Q05655 4/20 0.52
EGFR P00533 2/20 0.52
CDK2 P24941 2/20 0.52
CCNA2 P20248 1/20 0.52
CCNA1 P78396 1/20 0.52
AURKA O14965 1/20 0.51
CDK9 P50750 1/20 0.51
AURKB Q96GD4 1/20 0.51
KCNH2 Q12809 1/20 0.51
BCR P11274 5/20 0.49
ZAP70 P43403 4/20 0.48
LRRK2 Q5S007 1/20 0.47
PRKD3 O94806 1/20 0.47
PRKCG P05129 1/20 0.47
PRKCB P05771 1/20 0.47
LCK P06239 1/20 0.47
PRKCH P24723 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29618359 1.00 ACVR1 (0.54) ACVR1ABL1PRKCAPRKCDEGFR
SCHEMBL29618431 0.91 ACVR1 (0.58) ACVR1ABL1PRKCAPRKCDEGFR
SCHEMBL29618396 0.88 CCNA2 (0.65) ACVR1ABL1PRKCAPRKCDEGFR
SCHEMBL29618397 0.88 CCNA2 (0.65) ACVR1ABL1PRKCAPRKCDEGFR
SCHEMBL23245920 0.87 KCNH2 (0.47) ACVR1ABL1PRKCAPRKCDEGFR
SCHEMBL29618365 0.87 KCNH2 (0.47) ACVR1ABL1PRKCAPRKCDEGFR
SCHEMBL29618440 0.86 ABL1 (0.60) ACVR1ABL1PRKCAPRKCDEGFR
SCHEMBL29618389 0.85 ACVR1 (0.57) ACVR1ABL1PRKCAPRKCDEGFR
SCHEMBL29883957 0.84 LMNA (0.51) CDK2AURKACDK9AURKBKCNH2
SCHEMBL29618422 0.83 JAK2 (0.62) ACVR1ABL1PRKCAPRKCDEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114502555-A Derivatives of 4- (imidazo [1,2-a ] pyridin-3-yl) -N- (pyridin-3-yl) pyrimidin-2-amines for the treatment of proliferative diseases and disorders 常州千红生化制药股份有限公司 2022-05-13 CN disclosed